Postoperative recurrence of Crohn's disease: the beginning of the end?
Sorrentino
Dario
D
Paviotti
Alberto
A
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000601:surgery*; D006801:Humans; D000069285:Infliximab; D007422:Intestines / Q000601:surgery; D055502:Secondary Prevention
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab